Search clinical trials for: AQUACEL® AG

Total 14174 results

Agios Pharmaceuticals, Inc.

Completed

A Study of AG-120 (Ivosidenib) in Subjects With Mild or Moderate Hepatic Impairment or Normal Hepatic Function

Hepatic Impairment

United States
Queen Elizabeth II Health Sciences Centre

Unknown

The Safety and Immunogenicity of Acellular Pertussis Vaccine in Bone Marrow Transplant Recipients

Pertussis
Agios Pharmaceuticals, Inc.

Recruiting

A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP)

Sickle Cell Disease

United Kingdom, United States, Belgium, Netherlands, Germany, Canada, Brazil, France, Israel, Italy, Lebanon, Oman, Ghana, Kenya, Nigeria, Saudi Arabia, Turkey
Institute of Cancer Research, United Kingdom
Royal Marsden NHS Foundation Trust; Pfizer

Completed

A Phase II Study of Axitinib in Patients With Metastatic Renal Cell Cancer Unsuitable for Nephrectomy (A-PREDICT)

Clear-cell Metastatic Renal Cell Carcinoma

United Kingdom
bioLytical Laboratories

Completed

Evaluation of Clinical Performance and Usability of iStatis COVID-19 Ag Rapid Test at POC

COVID-19 | SARS-CoV-2 Infection | COVID-19 Pandemic | COVID-19 Virus Infection | Coronavirus Disease-19

United States
University of Wisconsin, Madison
Pfizer

Completed

Pharmacodynamic Study of Axitinib in Patients With Advanced Solid Malignancies

Neoplasms

United States
Pfizer

Completed

Study Of AG-013736 (Axitinib) As Second-Line Treatment In Patients With Metastatic Renal Cell Cancer (mRCC)

Carcinoma, Renal Cell

Japan
National Taiwan University Hospital
Taipei Veterans General Hospital, Taiwan; Tri-Service General Hospital

Completed

Axitinib as Second-line Treatment for Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma

Taiwan
National Cancer Institute (NCI)
Children's Oncology Group

Active, not recruiting

Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial)

Refractory Malignant Solid Neoplasm | Recurrent Ependymoma | Recurrent Ewing Sarcoma | Recurrent Hepatoblastoma | Recurrent Langerhans Cell Histiocytosis | Recurrent Malignant Germ Cell Tumor | Recurrent Malignant Glioma | Recurrent Malignant Solid Neoplasm | Recurrent Medulloblastoma | Recurrent Neuroblastoma and other conditions

United States, Puerto Rico, Australia
Rigshospitalet, Denmark
Emergency Medical Services, Capital Region, Denmark; Technical University of... and other collaborators

Completed

Diagnostic Accuracy of Self-sampling Versus Healthcare Sampling for Coronavirus-Disease-2019 Detection. (COVID-19)

COVID-19 Pandemic

Denmark
Mahidol University

Completed

2-year Follow-up After a Single Dose Acellular Pertussis Vaccination

Pertussis

Thailand
Mahidol University

Completed

3-year Follow-up After a Single Dose Acellular Pertussis Vaccination

Pertussis

Thailand
Institut de Recherches Internationales Servier

Completed

Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation

Glioma | Cholangiocarcinoma | Chondrosarcoma | Other Advanced Solid Tumors

United States, France
American Genomics, LLC

Completed

An Open Label, Study of the Systemic Exposure to Articaine After Topical Ocular Dosing of AG-920

Healthy

United States
Agios Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Mitapivat (AG-348) in Healthy Adult Participants

Healthy Volunteers

United States
Agios Pharmaceuticals, Inc.

Completed

Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-AG-120

Healthy Volunteers

United States
Pfizer

Completed

Evaluation Of Hepatic Impairment On AG-013736 Pharmacokinetics

Hepatic Insufficiency

United States
GCAM Inc.

Completed

Tdap Vaccine Safety for Plasma Donors

Tetanus

United States
Lynkcell Europe

Enrolling by invitation

Phase I Clinical Trials Investigating the Potential Efficacy of Axitinib in Patients With a BRCA 1/2 Mutations

Breast Cancer | Breast Neoplasms | Ovarian Neoplasms | Ovarian Cancer | HER2-positive Breast Cancer | HER2-negative Breast Cancer | HER-2 Protein Overexpression | BRCA Mutation

Ukraine
Pfizer

Completed

Food Effect Study Of AG-013736 In Healthy Volunteers

Healthy Volunteers

Belgium
Institut de Recherches Internationales Servier

Active, not recruiting

Study of AG-120 and AG-881 in Subjects With Low Grade Glioma

Glioma

United States
M.D. Anderson Cancer Center
Pfizer

Completed

Neoadjuvant Axitinib in Locally Advanced Renal Cell Carcinoma (RCC)

Kidney Cancer

United States
National Institute of Allergy and Infectious Diseases...
Immuno-US

Completed

A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals

HIV Infections

United States
Sheffield Teaching Hospitals NHS Foundation Trust
Pfizer; Cancer Research UK; University of Birmingham

Completed

A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas (Axi-STS)

Soft Tissue Sarcoma

United Kingdom
Yale University

Withdrawn

A Study of the IDH1 Inhibitor AG-120 in Combination With the Checkpoint Blockade Inhibitor, Nivolumab, for Patients With IDH1 Mutated Relapsed/Refractory AML and High Risk MDS

Acute Myeloid Leukemia | Myelodysplastic Syndromes

United States
University of North Carolina, Chapel Hill
National Institute on Drug Abuse (NIDA); National Institute on Alcohol Abuse... and other collaborators

Completed

Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth

HIV Infection | Hepatitis B

Brazil, United States, South Africa
Pfizer

Completed

Study Of AG-013736 In Patients With Refractory Metastatic Renal Cell Cancer

Kidney Neoplasms | Carcinoma, Renal Cell

United States
Pfizer

Completed

A Bioequivalence Study Of AG-013736 Tablets Under Fed Conditions In Healthy Volunteers

Healthy Volunteer

Singapore
Maastricht University Medical Center
Dutch Heart Foundation; Center for Translational Molecular Medicine

Completed

ParisK: Correlation of Imaging Techniques With Histology (ParisK)

Stroke | Plaque, Atherosclerotic

Netherlands
University Health Network, Toronto
Pfizer

Completed

Study of Axitinib in Patients With Unresectable Hepatocellular Carcinoma (AXITINIB)

Hepatocellular Carcinoma

Canada
University Hospital Heidelberg

Completed

A Randomized Trial Comparing 2 Methods for Rapid Induction of Cooling in Stroke Patients, Cold Infusions vs. EMCOOLS Brain.Pad (iCOOL 3) (iCOOL 3)

Ischemic Stroke | Hemorrhagic Stroke

Germany
Pfizer

Completed

Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma

Melanoma | Skin Neoplasms

United States, France
Pfizer

Completed

Study Of AG-013736 (Axitinib) In Patients With Advanced Solid Tumors

Carcinoma

Japan
Institut de Recherche en Sciences de la Sante,...

Recruiting

Algorithm Using a Rapid Diagnostic Test for the Management of Childhood Febrile Diseases. (e-MANIC)

Antimicrobial Resistance

Burkina Faso
Columbia University
Pfizer

Recruiting

Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma

Pheochromocytoma | Paraganglioma

United States
Agios Pharmaceuticals, Inc.

Active, not recruiting

A Study to Determine the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AG-348 in Adult Participants With Non-transfusion-dependent Thalassemia

Thalassemia

United States, Canada, United Kingdom
Northwestern University

Terminated

Anterior-segment OCT (AS-OCT) and Intraoperative OCT (iOCT) for Trans- Conjunctival Needle Revision (TCNR)

Glaucoma | Glaucoma Following Surgery

United States
Indiana University
University of Alabama at Birmingham; University of Ottawa

Completed

G-EO Gait Rehabilitation Training in Progressive Multiple Sclerosis

Progressive Multiple Sclerosis

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines in Vaccinia-Naive Individuals

HIV Infections

United States
Pfizer

No longer available

Clinical Study With Axitinib In Advanced Kidney Cancer, Who Have Failed First Line Treatment

Renal Cell Carcinoma

Australia, Canada
Pfizer

Completed

Axitinib Pharmacokinetics in Chinese Healthy Volunteers

Healthy Volunteers

China
National Cancer Institute (NCI)

Completed

Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/Paraganglioma

Pheochromocytoma | Paraganglioma

United States
Firat University
Dicle University

Completed

Associations of Alveolar Bone Loss and Interleukin-1β Levels in One and Two Stage Surgical Procedures

Alveolar Bone Loss | Implant Infection

Turkey
Pfizer

Withdrawn

A Phase 2 Study Exploring The Safety And Efficacy Of Novel Drug Treatment In Subjects With Diabetic Macular Edema (DME)

Diabetes Mellitus | Diabetic Retinopathy
Pfizer

Completed

Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer

Thyroid Neoplasms

United States, Canada, Czech Republic, Poland, China, Italy, Spain, India, United Kingdom
Pfizer

Completed

A Study In Patients With Advanced Solid Tumor

Neoplasms

Japan
Pfizer

Completed

First In Human, Phase 1 Study of AG013736 In Patients With Solid Tumors

Advanced Solid Tumors

United States
Axio Biosolutions Pvt. Ltd.

Recruiting

To Evaluate the Efficacy and Safety of MaxioCel Versus Aquacel Extra for the Management of Chronic Wounds

Wound

India
Kaiser Clinic and Hospital

Completed

Aquanet Bowel Cleansing Device Versus Oral Sodium Picosulfate for Pre-endoscopy Bowel Preparation

Bowel Preparation

Brazil
Samsung Medical Center

Recruiting

Effect of Prophylactic Medical Compression Therapy on the Reduction of Breast Cancer-related Lymphedema in Patients With Adjuvant Docetaxel Chemotherapy: a Randomized Controlled Study

Breast Cancer Lymphedema

Korea, Republic of

Search clinical trials for: AQUACEL® AG

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malawi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations